GEOPOLITICS | US Opens Section 301 Probe Into Germany Over Pharmaceuticals
2026-06-19 05:00:06
The US has started a Section 301 tariff investigation into Germany over what it called “persistent underpayment for innovative pharmaceutical products,” setting the stage for possible retaliatory levies on German goods. According to Bloomberg, the probe could lead to tariffs in response to the US allegations.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
地缘政治 | 美国对德国药品启动301调查
